RNA-seq Reveals Aurora Kinase–Driven mTOR Pathway Activation in Patients with Sarcomatoid Metastatic Renal Cell Carcinoma

Renal Cell ◽

Aurora Kinase ◽

Mtor Pathway ◽

Rna Seq ◽

Pathway Activation

Impact of clinicopathological variables on mTOR Pathway activation in primary renal cell carcinoma (RCC) and matched metastases

Journal of the American College of Surgeons ◽

10.1016/j.jamcollsurg.2010.06.342 ◽

2010 ◽

Vol 211 (3) ◽

pp. S129

Author(s):

Alexander Kutikov ◽

Zachary Piotrowski ◽

Brian L. Egleston ◽

Min Huang ◽

Tahseen Al-Saleem ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Mtor Pathway ◽

Primary Renal Cell Carcinoma ◽

Pathway Activation ◽

Clinicopathological Variables

Expression and prognostic significance of VEGF and mTOR pathway proteins in metastatic renal cell carcinoma patients: a prognostic immunohistochemical profile for kidney cancer patients

World Journal of Urology ◽

10.1007/s00345-016-1890-7 ◽

2016 ◽

Vol 35 (3) ◽

pp. 411-419 ◽

Cited By ~ 6

Author(s):

Michalis Liontos ◽

Eleni-Andriana Trigka ◽

Penelope Korkolopoulou ◽

Kimon Tzannis ◽

Giorgos Lainakis ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Cancer Patients ◽

Kidney Cancer ◽

Renal Cell ◽

Prognostic Significance ◽

Mtor Pathway ◽

Immunohistochemical Profile

Activating genomic mutations in the mTOR pathway to predict responses to everolimus and temsirolimus in patients with metastatic renal cell carcinoma (mRCC): Results from a large multi-institutional cohort.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.4519 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 4519-4519 ◽

Cited By ~ 1

Author(s):

Andre Poisl Fay ◽

David J. Kwiatkowski ◽

Kathryn P. Gray ◽

Aaron Thorner ◽

Brian I. Rini ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Mtor Pathway

MTOR PATHWAY ACTIVATION IN PRIMARY RENAL CELL CARCINOMA (RCC) AND MATCHED METASTASES

10.1016/s0022-5347(09)61413-0 ◽

2009 ◽

Vol 181 (4S) ◽

pp. 500-500 ◽

Cited By ~ 1

Author(s):

Alexander Kutikov ◽

Brian L. Egleston ◽

Tasha Morrison ◽

Elizabeth P Henske ◽

Min Huang ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Mtor Pathway ◽

Primary Renal Cell Carcinoma ◽

Pathway Activation

114 Clonal mTOR pathway activation as a predictive biomarker for mTOR inhibitor therapy in clear cell renal cell carcinoma

European Urology Supplements ◽

10.1016/s1569-9056(16)60116-1 ◽

2016 ◽

Vol 15 (3) ◽

pp. e114-e114a

Author(s):

M. Stares ◽

D. Nicol ◽

T. O'Brien ◽

B. Challacombe ◽

A. Rowan ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Mtor Inhibitor ◽

Clear Cell ◽

Predictive Biomarker ◽

Mtor Pathway ◽

Inhibitor Therapy ◽

Cell Renal Cell Carcinoma ◽

Pathway Activation

1255: Potential Role of Postoperative Azotemia in Predicting Response to Interleukin-2 (IL-2) Immunotherapy Following Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma

10.1016/s0022-5347(18)31469-1 ◽

2007 ◽

Vol 177 (4S) ◽

pp. 414-414

Author(s):

John S. Lam ◽

Rakhee H. Gael ◽

Tobias Klatte ◽

Fairooz F. Kabbinavar ◽

Arie S. Belldegrun ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Potential Role ◽

Interleukin 2 ◽

Cytoreductive Nephrectomy

1103: Laparoscopic Salvage Nephrectomy after Targeted Neoadjuvant Therapy for Metastatic Renal Cell Carcinoma: Initial Results

10.1016/s0022-5347(18)31317-x ◽

2007 ◽

Vol 177 (4S) ◽

pp. 364-364 ◽

Cited By ~ 1

Author(s):

Surena F. Matin ◽

Christopher G. Wood ◽

Shi-Ming Tu ◽

Nizar M. Tannir ◽

Eric Jonasch

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Neoadjuvant Therapy ◽

Renal Cell ◽

Initial Results

637: Establishing a Porcine Model for the Accelerated Development of Cancer Vaccines for Patients with Metastatic Renal Cell Carcinoma

10.1016/s0022-5347(18)34877-8 ◽

2005 ◽

Vol 173 (4S) ◽

pp. 173-174

Author(s):

Quinton V. Cancel ◽

Benjamin K. Yang ◽

Zhen Su ◽

Jens Dannull ◽

Philipp Dahm ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Cancer Vaccines ◽

Porcine Model

1716: Pharmaco-Angio-CT is Superior to 4 Phase Helical CT in the Detection of Recurrent Metastatic Renal Cell Carcinoma

10.1016/s0022-5347(18)33895-3 ◽

2006 ◽

Vol 175 (4S) ◽

pp. 551-552

Author(s):

Erich K. Lang ◽

Richard J. Macchia ◽

Raju Thomas ◽

Ronald Davis ◽

Douglas Slakey ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Helical Ct ◽

Angio Ct

396: HSP27 Expression in Primary and Metastatic Renal Cell Carcinoma

10.1016/s0022-5347(18)32652-1 ◽

2006 ◽

Vol 175 (4S) ◽

pp. 129-129

Author(s):

Richard E. Zigeuner ◽

Nikolaus Droschl ◽

Volkmar Tauber ◽

Peter Rehak ◽

Cord Langner

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Hsp27 Expression